Celgene Corp /De/ Crispr Therapeutics Ag (CRSP) insider trading activity

CRSP Quotes by TradingView

Celgene Corp /De/ is > 10% Shareholder of CRISPR Therapeutics AG. Currently has a direct ownership of 4.83 Million shares of CRSP, which is worth approximately $231 Million. The most recent transaction as insider was on Oct 24, 2016, when has been sold 800,150 shares (Common Stock) at a price of $14.0 per share, resulting in proceeds of $11,202,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.83M
0% 3M change
0% 12M change
Total Value Held $231 Million

CELGENE CORP /DE/ Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 24 2016
BUY
Open market or private purchase
$11,202,100 $14.0 p/Share
800,150 Added 14.2%
4,834,980 Common Stock
Oct 24 2016
BUY
Conversion of derivative security
-
4,034,830 Added 50.0%
4,034,830 Common Stock

Also insider at

XLRN
ACCELERON PHARMA INC Healthcare
> 10% Shareholder
CC/

Celgene Corp /De/

> 10% Shareholder
Summit, NJ

Track Institutional and Insider Activities on CRSP

Follow CRISPR Therapeutics AG and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRSP shares.

Notify only if

Insider Trading

Get notified when an Crispr Therapeutics Ag insider buys or sells CRSP shares.

Notify only if

News

Receive news related to CRISPR Therapeutics AG

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CRSP